The University of Southampton
University of Southampton Institutional Repository

A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression

A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression
A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression
Objective
We hypothesized that combining antidepressant medication with a standardized telephone adherence support intervention would lead to superior outcomes in the treatment of depression compared with antidepressant medication alone.

Method
Patients with depression were randomized to receive the antidepressant duloxetine alone (DLX), or duloxetine plus a standardized telephone intervention (DLX + TI), for 12 weeks of open-label treatment. The primary outcome measure was remission (HAMD17 total score ? 7) at study endpoint. Safety and tolerability were assessed via reporting of treatment-emergent adverse events (AEs), vital signs and laboratory measures. The TI was delivered approximately 1, 4, and 9 weeks after initiation of duloxetine.

Results
The DLX (N = 485) and DLX + TI (N = 477) groups did not differ significantly at baseline. At study endpoint, remission rates (42.8% vs. 43.5%, P = 0.87), response rates (56.6% vs. 58.4%, P = 0.58) and other secondary outcomes were similar between the groups. A similar proportion of patients in each group completed the study, and adverse event discontinuation rates were not significantly different (10.7% vs. 13.0%, P = 0.318). More AEs were reported by patients in the DLX + TI group, however, and constipation (3.5% vs. 10.1%, P < 0.001) and hot flush (0.2% vs. 1.7%, P = 0.020) were reported by more DLX + TI patients. Adherence to medication was high (> 90% at every visit) in both groups.

Conclusions
A telephone intervention in combination with antidepressant medication (duloxetine) did not improve depression outcomes compared with antidepressant alone in this clinical trial, perhaps due to high drug adherence in both treatment groups. Addition of a telephone intervention was, however, associated with increased reporting of AEs.
duloxetine, major depressive disorder, telephone intervention, adherence
0165-0327
33-41
Perahia, David G.S.
5fd14550-cc63-417e-9bf5-69ef2c17e3b6
Quail, Deborah
92750eb7-8c18-44ad-a800-ae6830cd1a1e
Gandhi, Paul
e63eb0bf-2a69-49e3-a989-e09ee4d221a4
Walker, Daniel J.
46f91ff9-ef1d-482a-8a7e-7706515b20c8
Peveler, Robert C.
93198224-78d9-4c1f-9c07-fdecfa69cf96
Perahia, David G.S.
5fd14550-cc63-417e-9bf5-69ef2c17e3b6
Quail, Deborah
92750eb7-8c18-44ad-a800-ae6830cd1a1e
Gandhi, Paul
e63eb0bf-2a69-49e3-a989-e09ee4d221a4
Walker, Daniel J.
46f91ff9-ef1d-482a-8a7e-7706515b20c8
Peveler, Robert C.
93198224-78d9-4c1f-9c07-fdecfa69cf96

Perahia, David G.S., Quail, Deborah, Gandhi, Paul, Walker, Daniel J. and Peveler, Robert C. (2008) A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression. Journal of Affective Disorders, 108 (1-2), 33-41. (doi:10.1016/j.jad.2007.08.023).

Record type: Article

Abstract

Objective
We hypothesized that combining antidepressant medication with a standardized telephone adherence support intervention would lead to superior outcomes in the treatment of depression compared with antidepressant medication alone.

Method
Patients with depression were randomized to receive the antidepressant duloxetine alone (DLX), or duloxetine plus a standardized telephone intervention (DLX + TI), for 12 weeks of open-label treatment. The primary outcome measure was remission (HAMD17 total score ? 7) at study endpoint. Safety and tolerability were assessed via reporting of treatment-emergent adverse events (AEs), vital signs and laboratory measures. The TI was delivered approximately 1, 4, and 9 weeks after initiation of duloxetine.

Results
The DLX (N = 485) and DLX + TI (N = 477) groups did not differ significantly at baseline. At study endpoint, remission rates (42.8% vs. 43.5%, P = 0.87), response rates (56.6% vs. 58.4%, P = 0.58) and other secondary outcomes were similar between the groups. A similar proportion of patients in each group completed the study, and adverse event discontinuation rates were not significantly different (10.7% vs. 13.0%, P = 0.318). More AEs were reported by patients in the DLX + TI group, however, and constipation (3.5% vs. 10.1%, P < 0.001) and hot flush (0.2% vs. 1.7%, P = 0.020) were reported by more DLX + TI patients. Adherence to medication was high (> 90% at every visit) in both groups.

Conclusions
A telephone intervention in combination with antidepressant medication (duloxetine) did not improve depression outcomes compared with antidepressant alone in this clinical trial, perhaps due to high drug adherence in both treatment groups. Addition of a telephone intervention was, however, associated with increased reporting of AEs.

Full text not available from this repository.

More information

e-pub ahead of print date: 10 October 2007
Published date: May 2008
Keywords: duloxetine, major depressive disorder, telephone intervention, adherence
Organisations: Faculty of Medicine

Identifiers

Local EPrints ID: 62534
URI: http://eprints.soton.ac.uk/id/eprint/62534
ISSN: 0165-0327
PURE UUID: 7e9330f7-7cb1-4bd2-861e-bbcb88f2187a
ORCID for Robert C. Peveler: ORCID iD orcid.org/0000-0001-5596-9394

Catalogue record

Date deposited: 06 Apr 2009
Last modified: 17 Dec 2019 02:02

Export record

Altmetrics

Contributors

Author: David G.S. Perahia
Author: Deborah Quail
Author: Paul Gandhi
Author: Daniel J. Walker

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×